• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested

    6/18/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care
    Get the next $NIVF alert in real time by email

    K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion

    NewGen's expanded stake and exclusive Asia-Pacific agency rights deepen its strategic participation in K25.ai's next phase of growth

    BANGKOK, June 18, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has executed an agreement for a further US$4 million strategic investment in K25.ai. The transaction completes K25.ai's US$10 million Pre-A round at a US$100 million valuation and, upon completion and satisfaction of the applicable closing conditions, is expected to increase NewGen's aggregate ownership interest in K25.ai to 10%. With the Pre-A round now closed, K25.ai has commenced its Series A fundraising.

    The investment follows NewGen's initial US$2 million investment announced in May 2026 and its subsequent US$4 million investment announced on June 4, 2026. The completed US$10 million Pre-A provides K25.ai with strategic backing as it moves toward product launch, while the newly launched Series A is intended to support commercialization, applicable regulatory licensing and expansion across selected Asian markets.

    K25.ai is an AI-native livestreaming and watch-to-predict information market platform purpose-built for Asia-Pacific. Positioned as "Twitch × Polymarket × ChatGPT," K25.ai is developing a new category of interactive information markets that combines creator-led livestreaming, AI-assisted market creation and resolution, and real-time community participation.

    NewGen believes the expanded investment provides early strategic exposure to a differentiated platform operating at the convergence of artificial intelligence, livestreaming and prediction-market infrastructure. The transaction reflects NewGen's conviction in the long-term potential of AI-powered information markets and K25.ai's ability to build a category-defining platform for Asia-Pacific, subject to execution, market conditions and applicable regulatory requirements.

    Beyond its equity ownership, NewGen holds exclusive Asia-Pacific agency rights with K25.ai, creating an additional commercial pathway to support regional partnerships and distribution across permitted markets. Together, the expected 10% ownership position and agency relationship would provide NewGen with meaningful economic participation and strong strategic alignment with K25.ai's regional growth.

    Alfred Siu, Founder, Chairman and Chief Executive Officer of NewGen, commented, "Entering into this additional agreement to complete our aggregate US$10 million commitment to K25.ai and securing an expected 10% ownership position at the same US$100 million Pre-A valuation represents a compelling strategic milestone for NewGen. We believe K25.ai is building a highly differentiated platform at the intersection of AI, livestreaming and information markets. Together with our exclusive Asia-Pacific agency rights, this expanded investment positions NewGen to participate meaningfully in K25.ai's product launch, commercialization and next phase of regional growth."

    Andy Cheung, Founder and Chief Executive Officer of K25.ai, commented, "The successful close of our US$10 million Pre-A at a US$100 million valuation marks a defining milestone for K25.ai and provides strong strategic validation for our vision of building Asia-Pacific's next-generation AI-powered information market. With NewGen's backing, our Pre-A is now complete and we have officially commenced our Series A fundraising. We are raising this Series A at a meaningful step-up valuation, which we believe reflects the strong momentum and investor interest K25.ai has generated since our Pre-A. This next round is designed to accelerate product launch, advance applicable regulatory licensing in selected Asian markets, deepen our creator and strategic partner ecosystem, and position K25.ai for its next phase of regional growth."

    Further details regarding the Agreement and the proposed transaction will be included in a Form 6-K to be furnished to the U.S. Securities and Exchange Commission.

    About K25.ai

    K25.ai is an AI-native information market platform combining livestreaming, AI-assisted market creation and resolution, and interactive watch-to-predict experiences. Purpose-built for Asia-Pacific and positioned as "Twitch × Polymarket × ChatGPT," K25.ai is developing a creator-led platform for sports, esports, entertainment and other permitted event categories. The platform is progressing toward product launch and pursuing applicable regulatory licensing in selected markets. K25.ai does not offer services in jurisdictions where such activities are restricted or prohibited. To learn more, visit www.k25.ai.

    About NewGenIVF Group Limited

    NewGenIVF Group Limited is a technology-forward, diversified growth company pursuing opportunities across real estate development, digital asset innovation and reproductive health solutions. The Company operates through NewGenProperty, focused on real estate development projects in Ras Al Khaimah, United Arab Emirates; NewGenDigital, focused on digital asset and decentralized-finance solutions; and NewGenSup, focused on health and longevity products and solutions. NewGenIVF's legacy business includes IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. Information contained on, or accessible through, the Company's website is not incorporated by reference into this press release.

    Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "outlook," "would," "may," "potential," "aim," "seek," "project," "positions," "conviction," "intends," "designed to," and similar expressions, or their negatives, although not all forward-looking statements contain these identifying words. These statements include, among others, statements regarding the proposed investment in K25.ai, the expected completion of the transaction, NewGen's anticipated ownership interest, K25.ai's planned product launch, future financing initiatives, regulatory licensing efforts, regional expansion and growth prospects, and the expected strategic and commercial benefits of the relationship between NewGen and K25.ai. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including the risk that the transaction may not be completed on the anticipated terms or at all; the risk that closing conditions may not be satisfied, including the Company's ability to fund its remaining payment obligations under the agreement; market, regulatory and financing conditions; K25.ai's ability to develop and launch its platform, obtain applicable licenses and execute its growth strategy; and other risks described in NewGen's filings with the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. NewGen undertakes no obligation to update any forward-looking statement, except as required by law. This press release is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities of NewGenIVF Group Limited, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

    Contacts

    NewGen Investor Relations Contact

    ICR, LLC

    Robin Yang

    Phone: +1 (212) 537-3847

    Email: NewgenivfIR@icrinc.com

    K25.ai Media Contact

    Email: media@k25.ai

    K25.ai Investor Relations Contact

    Email: ir@k25.ai



    Get the next $NIVF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NIVF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NIVF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 3 filed by new insider Chung Ho Fai

    3/A - NewGenIvf Group Ltd (0001981662) (Issuer)

    6/16/26 6:04:07 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Large owner Hrt Financial Lp sold $50,722 worth of shares (64,945 units at $0.78), decreasing direct ownership by 78% to 18,134 units (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    6/8/26 3:11:25 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Director Siu Wing Fung Alfred exercised 56,851 units of Class B Ordinary Shares at a strike of $0.00, increasing direct ownership by 189,503% to 56,881 units (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    6/5/26 11:14:50 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization

    BANGKOK, June 22, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that NewGen’s total outstanding shares now stand at 10,073,535 following share issuances in connection with its strategic share purchase agreements to acquire a 10% equity interest in K25.ai. The Company’s market capitalization reached US$7,631,710 on June 18, 2026, providing a solid foundation for future growth. Management views this market capitalization as representing a substantial discount to the Company’s net asset value of approximately US$25.98 million as of December 31, 2025. The balance sheet has been further strengthened by the Company’s subsequent US$10 m

    6/22/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested

    K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion NewGen's expanded stake and exclusive Asia-Pacific agency rights deepen its strategic participation in K25.ai's next phase of growth BANGKOK, June 18, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has executed an agreement for a further US$4 million strategic investment in K25.ai. The transaction completes K25.ai's US$10 million Pre-A round at a US$100 million valuation and, upon completion and satisfaction of the ap

    6/18/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure

    NewGen to repurchase all outstanding convertible notes and warrants previously held by a significant investor in move to strengthen its capital structure Settlement to eliminate potential dilution from convertible notes and warrants Company views that this will position the Company's market capitalization to be undervalued relative to net assets BANGKOK, June 16, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that it has entered into a Repurchase and Forbearance Agreement (the "Settlement Agreement") with a significant investor (the "Investor"). Under the terms of the Settlement Agreement, NewGen will repurchase all outstandi

    6/16/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $32,000 worth of shares (34,756 units at $0.92), increasing direct ownership by 72% to 83,079 units (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    6/4/26 4:08:25 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Large owner Hrt Financial Lp bought $161,919 worth of shares (165,534 units at $0.98) (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    5/27/26 1:19:20 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    SEC Filings

    View All

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    6/22/26 9:41:59 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    6/18/26 8:30:09 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    6/16/26 8:30:01 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Financials

    Live finance-specific insights

    View All

    NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress

    NewGen records strong balance sheet with total assets of US$32.7 million Net profit attributable to shareholders of the Company of US$9.9 million BANGKOK, May 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today outlined several highlights of its fiscal year 2025 results and the steady progress of its continued strategic transformation. More information on NewGen's results can be found in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, (the "2025 Annual Report") which was filed with the U.S. Securities and Exchange Commission (the "SEC") in April 2026. The ful

    5/4/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    12/5/24 8:23:57 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    11/13/24 9:19:27 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    10/10/24 3:39:26 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Leadership Updates

    Live Leadership Updates

    View All

    NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy

    NewGen's 6% Stake in K25.ai Now Valued at US$6 MillionCompany will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced it has exercised its top-up option to acquire an additional 4% equity interest in AI-native livestreaming prediction market platform K25.ai, raising its total holding to 6%. The additional US$4 million investment, which supplements an initial US$2 million investment announced in May 2026, is split evenly between cash and newly issued NewGen Class A ordinary shares.

    6/4/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts

    BANGKOK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (("NewGen" or the "Company, NASDAQ:NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced the appointment of award-winning Web3 legal and regulatory specialist Joshua Chu as Senior Counsel to lead the Group's tokenization strategy, alongside the formal engagement of Evident Capital, Hong Kong's first fully integrated, SFC-licensed tokenization and alternative assets platform, to support the launch of NIVF's inaugural tokenized bond issuance of up to USD 30 million targeted for completion by the first quarter of 2026. As S

    1/21/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenDigital Appointed as SAXA Inc.'s Agent for Tokenization of US$100 Million of Gold-backed Assets

    Service agreement with SAXA, Inc. appoints NewGenDigital as SAXA's worldwide tokenization agent, strengthening cooperation between the two companies ahead of proposed reverse merger Value of tokenized assets could be expanded to US$1 billion under the terms of the agreement; NewGenDigital to earn 5% commission on assets sold BANGKOK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that its subsidiary, NewGenD

    11/5/25 9:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care